Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Riv Psichiatr ; 59(2): 52-59, 2024.
Article in English | MEDLINE | ID: mdl-38651773

ABSTRACT

INTRODUCTION: Prenatal alcohol exposure causes a variety of impairments to the fetus called Fetal Alcohol Spectrum Disorders (FASD). Since it is very difficult to identify women that consume alcohol during pregnancy, different methods have been studied to evaluate alcohol exposure. Ethyl Glucuronide (EtG) and Fatty Acid Ethyl Esters (FAEEs) are commonly used to measure alcohol consumption in individuals at-risk for alcohol abuse, including pregnant women. MATERIALS AND METHODS: We conducted a study of two cohorts of 1.5 year-old infants (of mothers without a history of alcohol abuse) with or without meconium samples positive to both EtG and FAEEs and we evaluated their cognitive-behavioral development by the Griffiths Mental Developmental Scale (GMDS) method. Our protocol included 8 infants with meconium positive to alcohol metabolites (EtG and FAEEs) and 7 with meconium negative to alcohol metabolites. RESULTS: None of the 8 alcohol metabolites positive meconium infants exhibited distinctive facial features and growth retardation of severe FASD, showing that other factors may contribute to the FASD onset but elevations in EtG and FAEEs in the meconium were significantly associated with disrupted neurodevelopment and adaptive functions within the first year and a half of life. Indeed, we found out that infants with meconium positive for both EtG and FAEEs, although without displaying any FASD morphological features, had a delay in the fine regulation of their own locomotory capabilities. CONCLUSIONS: Further analyses and larger studies are needed to estimate the right link between prenatal alcohol exposure and the different range of disorders connected but this study provides an additional step in the field of FASD in order to suggest early treatments for at-risk newborns and infants.


Subject(s)
Biomarkers , Fetal Alcohol Spectrum Disorders , Glucuronates , Meconium , Humans , Meconium/chemistry , Meconium/metabolism , Pilot Projects , Female , Fetal Alcohol Spectrum Disorders/metabolism , Biomarkers/metabolism , Glucuronates/analysis , Infant , Male , Pregnancy , Prenatal Exposure Delayed Effects , Fatty Acids/metabolism , Fatty Acids/analysis , Alcohol Drinking/adverse effects , Infant, Newborn , Locomotion , Esters/analysis , Child Development
2.
Riv Psichiatr ; 57(1): 1-9, 2022.
Article in English | MEDLINE | ID: mdl-35166724

ABSTRACT

Patients with alcohol use disorder (AUD) do not manifest homogeneous clinical symptoms. Various studies described both cognitive impairments and psychiatric disorders among people with AUD. This disorder is one of the most frequent mental disorders in developed countries, due to excessive alcohol consumption. Alcohol is toxic as it increases the production of reactive oxygen species (ROS) and can cause dependence. This causes negative effects on brain development and cognitive functions that affect the individual's work, health, and social life. Current pharmacology treatment for alcohol addiction is based on direct action against the neurotransmitters involved in alcohol dependence. AUD patients without comorbid psychiatric disorders or severe cognitive deficits are defined as "pure alcoholics". To date, poor is known about effective treatments for this typology of AUD patients. Psychotherapy is largely used in resolving many psychiatric disorders, including substance use disorders. Motivational enhancement therapy (MET) and cognitive-behavioral therapy (CBT) are two psychotherapies used to achieve and maintain abstinence in patients affected by substance use disorders. This short review aims to describe two CBT and MET and to present the advantages and disadvantages of these two psychotherapies in the treatment of AUD.


Subject(s)
Alcoholism , Cognitive Behavioral Therapy , Motivational Interviewing , Alcoholism/complications , Alcoholism/therapy , Humans , Psychotherapy , Treatment Outcome
3.
CNS Neurol Disord Drug Targets ; 21(9): 854-868, 2022.
Article in English | MEDLINE | ID: mdl-34852752

ABSTRACT

BACKGROUND: Fetal Alcohol Spectrum Disorders (FASD) are the manifestation of the damage caused by alcohol consumption during pregnancy. Children with Fetal Alcohol Syndrome (FAS), the extreme FASD manifestation, show both facial dysmorphology and mental retardation. Alcohol consumed during gestational age prejudices brain development by reducing, among others, the synthesis and release of neurotrophic factors and neuroinflammatory markers. Alcohol drinking also induces oxidative stress. HYPOTHESIS/OBJECTIVE: The present study aimed to investigate the potential association between neurotrophins, neuroinflammation, and oxidative stress in 12 prepubertal male and female FASD children diagnosed as FAS or partial FAS (pFAS). METHODS: Accordingly, we analyzed, in the serum, the level of BDNF and NGF and the oxidative stress, as Free Oxygen Radicals Test (FORT) and Free Oxygen Radicals Defense (FORD). Moreover, serum levels of inflammatory mediators (IL-1α, IL-2, IL-6, IL-10, IL-12, MCP-1, TGF-ß, and TNF-α) involved in neuroinflammatory and oxidative processes have been investigated. RESULTS: We demonstrated low serum levels of NGF and BDNF in pre-pubertal FASD children with respect to healthy controls. These changes were associated with higher serum presence of TNF- α and IL-1α. Quite interestingly, an elevation in the FORD was also found despite normal FORT levels. Moreover, we found a potentiation of IL-1α, IL-2, IL-10, and IL-1α1 in the analyzed female compared to male children. CONCLUSION: The present investigation shows an imbalance in the peripheral neuroimmune pathways that could be used in children as early biomarkers of the deficits observed in FASD.


Subject(s)
Fetal Alcohol Spectrum Disorders , Neuroinflammatory Diseases , Biomarkers/blood , Brain-Derived Neurotrophic Factor/blood , Child , Ethanol , Female , Fetal Alcohol Spectrum Disorders/diagnosis , Humans , Interleukins/blood , Male , Nerve Growth Factor/blood , Neuroinflammatory Diseases/diagnosis , Reactive Oxygen Species
4.
Riv Psichiatr ; 55(2): 79-89, 2020.
Article in English | MEDLINE | ID: mdl-32202545

ABSTRACT

Fetal Alcohol Spectrum Disorders (FASD) are a plethora of malformative conditions leading to mental retardation that affect newborns and children who have been exposed to alcohol during pregnancy or breastfeeding. FASD is a relevant topic for public health in Europe: European area is first in ranking for alcohol use during pregnancy with a prevalence of 25.2%. Italy ranked third among European countries with higher prevalence of FASD (45.0 per 1000 population). Furthermore, FASD could still be underestimated because of numerous undiagnosed and misdiagnosed cases. Aims of the study were to briefly summarize existing evidences about FASD and its psychiatric aspects to assess knowledge, attitudes and practice towards alcohol drinking during pregnancy in an Italian sample of health care professionals in order to provide information about FASD prevention. An anonymous online questionnaire containing the AUDIT-C, T-ACE model and the Drinking Motive Questionnaire was sent to 400 Italian healthcare professionals and students. The survey included socio-demographic information, questions about drinking habits and about knowledge, attitude and practice towards alcohol assumption during pregnancy. Among 320 respondents, 96.3% were women. AUDIT-C revealed that 52.4% were low risk drinkers but 27.6% were hazardous drinkers. The 90.6% of participants denied to ever attended a course about the fetus damage induced by alcohol consumption during pregnancy but 91.3% were willing to participate to professional update initiatives on the topic. Only 19.1% of participants talk regularly about the deleterious effects for the fetus of prenatal alcohol drinking to women and only 51.1% advise the 'zero alcohol' policy. Around 41% of participants tolerates the assumption of low-alcohol beverages. No differences were found between no drinkers and low and hazardous drinkers. In conclusion, data show that only specific and continuing updating for health care professionals about drinking habits may have impactful actions to prevent gestational alcohol intake in order to prevent the main cause of mental retardation in western countries.


Subject(s)
Alcohol Drinking/psychology , Fetal Alcohol Spectrum Disorders/psychology , Health Knowledge, Attitudes, Practice , Health Personnel/psychology , Alcohol Drinking/adverse effects , Alcohol Drinking/epidemiology , Analysis of Variance , Europe/epidemiology , Facies , Female , Fetal Alcohol Spectrum Disorders/diagnosis , Fetal Alcohol Spectrum Disorders/epidemiology , Fetal Alcohol Spectrum Disorders/prevention & control , Health Care Surveys/statistics & numerical data , Humans , Italy/epidemiology , Male , Midwifery , Physicians , Pregnancy , Psychiatry , Students, Health Occupations/psychology
5.
Addict Biol ; 25(3): e12724, 2020 05.
Article in English | MEDLINE | ID: mdl-30811093

ABSTRACT

Fetal alcohol spectrum disorders (FASDs) are a group of negative conditions occurring in children exposed to alcohol during gestation. The early discovery of FASD is crucial for mother and infant follow-ups. In this study, we investigated in pregnant women the association between urine ethylglucuronide (EtG-a biomarker of alcohol drinking) and indicators of the physical characteristics of FASD by prenatal ultrasound in the second trimester of gestation. We also correlated these data with the AUDIT-C, T-ACE/TACER-3, TWEAK, and food habit diary, screening questionnaires used to disclose alcohol drinking during pregnancy. Forty-four pregnant women were randomly enrolled and examined for ultrasound investigation during the second trimester of gestation. Urine samples were provided by pregnant women immediately after the routine interviews. EtG determinations were performed with a cutoff established at 100 ng/mL, a value indicating occasional alcohol drinking. Fifteen of the enrolled pregnant women overcame the EtG cutoff (34.09%). Analysis of variance (ANOVA) revealed that the fetuses of the positive EtG pregnant women had significantly longer interorbital distance and also significantly increased frontothalamic distance (P's < 0.02). Quite interestingly, no direct correlation was found between EtG data and both food diary and AUDIT-C. However, a significant correlation was observed between urinary EtG and T-ACE (r = 0.375; P = 0.012) and between urinary EtG and TWEAK (r = 0.512; P < 0.001) and a concordance with all questionnaire for EtG values higher than 500 ng/mL. This study provides clinical evidence that the diagnosis of maternal alcohol consumption during pregnancy by urine EtG may disclose FASD-related damage in the fetus.


Subject(s)
Alcohol Drinking , Brain/diagnostic imaging , Face/diagnostic imaging , Fetal Alcohol Spectrum Disorders/diagnostic imaging , Glucuronates/urine , Adult , Brain/embryology , Diet Records , Face/embryology , Female , Fetus , Humans , Mass Screening , Pregnancy , Pregnancy Trimester, Second , Risk Assessment , Surveys and Questionnaires , Ultrasonography, Prenatal , Young Adult
6.
Ann Ist Super Sanita ; 55(2): 131-142, 2019.
Article in English | MEDLINE | ID: mdl-31264636

ABSTRACT

AIM: In this study, we investigated in people suffering from alcohol use disorder (AUD) with or without dual diagnosis (concomitant psychiatric disability) how they feel their dependence condition. We predicted that AUD people with a dual diagnosis could feel potentiated their addiction. METHODS: Alcohol habits and psychiatric conditions of 183 AUD men and 62 AUD women were measured by using the DSM-5, the severity of alcohol dependence questionnaire (SADQ), the alcohol anamnesis and psychiatric examination by the symptom check list 90-R (SCL-90-R). RESULTS: We have shown that alcohol drinking does not correlate with both psychiatric examination and self-reported psychopathology. SADQ shows that severe alcohol dependence correlates with highest psychiatric symptoms and with the levels of alcohol consumption. CONCLUSIONS: This finding suggests that high SADQ scores may represent a tool to early disclose only patients with dual diagnosis. SADQ may provide information to address pharmacological interventions because revealing aspects of the dark side of addiction potentiated by AUD associated psychopathology.


Subject(s)
Alcoholism/psychology , Diagnosis, Dual (Psychiatry)/psychology , Severity of Illness Index , Adult , Alcoholism/epidemiology , Anxiety Disorders/epidemiology , Bipolar Disorder/epidemiology , Checklist , Comorbidity , Educational Status , Emotions , Female , Humans , Male , Middle Aged , Mood Disorders/epidemiology , Personality Disorders/epidemiology , Self Report , Smoking/epidemiology , Substance-Related Disorders/epidemiology , Symptom Assessment
7.
Riv Psichiatr ; 53(3): 118-122, 2018.
Article in English | MEDLINE | ID: mdl-29912213

ABSTRACT

Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.


Subject(s)
Alcohol Withdrawal Delirium/diagnosis , Ethanol/adverse effects , Alcohol Withdrawal Delirium/drug therapy , Alcohol Withdrawal Delirium/physiopathology , Alcohol Withdrawal Delirium/therapy , Alcohol Withdrawal Seizures/drug therapy , Alcohol Withdrawal Seizures/physiopathology , Alcoholism/blood , Alcoholism/complications , Anticonvulsants/therapeutic use , Antipsychotic Agents/adverse effects , Antipsychotic Agents/therapeutic use , Autonomic Nervous System/physiopathology , Benzodiazepines/administration & dosage , Benzodiazepines/therapeutic use , Combined Modality Therapy , Counseling , Delayed Diagnosis , Drug Therapy, Combination , Emergencies , Ethanol/blood , Humans , Kindling, Neurologic , Palliative Care , Severity of Illness Index , Symptom Assessment , Thiamine/therapeutic use
8.
Riv Psichiatr ; 53(3): 128-140, 2018.
Article in English | MEDLINE | ID: mdl-29912215

ABSTRACT

Alcohol use disorder (AUD) is one of the most common psychiatric disease in the general population, characterized by having a pattern of excessive drinking despite the negative effects of alcohol on the individual's work, medical, legal, educational, and/or social life. Currently, the bio-psycho-social model describes properly AUD as a multidimensional phenomenon including biological, psychological, and socio-cultural variables affecting the nature, maintenance, and expression of the disorder. The AUD diagnostic process is crucial since the treatment success depends heavily on the accuracy and the adequacy of the diagnosis. The diagnosis is based on a comprehensive assessment of the patient's characteristics and uses interviews and psychometric instruments for collecting information. This paper will provide insights into the most important psychological dimensions of AUD and on the best psychometric instruments for proposing AUD diagnosis.


Subject(s)
Alcoholism/diagnosis , Alcoholism/psychology , Cognition Disorders/chemically induced , Cognition Disorders/epidemiology , Comorbidity , Follow-Up Studies , Humans , Interpersonal Relations , Interview, Psychological , Mental Disorders/epidemiology , Motivational Interviewing , Outcome Assessment, Health Care , Personality Disorders/epidemiology , Psychological Tests , Psychometrics , Quality of Life , Severity of Illness Index , Symptom Assessment
9.
Riv Psichiatr ; 53(3): 141-148, 2018.
Article in English | MEDLINE | ID: mdl-29912216

ABSTRACT

The development of a treatment for alcohol use disorder (AUD) is a crucial and complex moment. Indeed, the information gathered by a team of professionals (physicians, psychologists and social workers) (bio-psycho-social model of AUD) interact to choose the most appropriate cure. As for AUD psychological treatment, it is of considerable importance to avoid clinical treatments leading to drop-out for improving the patients quality of life. Psychoanalytic and behavioral techniques were early utilized as psychological treatment of AUD, however, evidence-based approaches as motivational interviewing (MI) and cognitive behavioral therapy (CBT) are recently used in AUD. In this work we review the more effective and appropriate AUD psychological treatments.


Subject(s)
Alcoholism/therapy , Psychotherapy/methods , Alcoholism/economics , Alcoholism/prevention & control , Alcoholism/psychology , Clinical Trials as Topic , Cognitive Behavioral Therapy , Cost of Illness , Family Relations , Humans , Motivational Interviewing , Patient Compliance , Psychoanalysis , Psychotherapy/economics , Psychotherapy, Brief , Psychotherapy, Group , Recurrence , Self-Control , Self-Help Groups , Social Skills , Therapeutic Community , Treatment Outcome
10.
Riv Psichiatr ; 53(3): 149-153, 2018.
Article in English | MEDLINE | ID: mdl-29912217

ABSTRACT

Background: Clinical practice of mental health services changed in 1978 after the Basaglia Law was passed, and it is now characterized by usually voluntary treatments offered by community-based services. That broadened the interventions' focus from the single subject to their environment. Dual diagnosis is defined by WHO as «the co-occurrence in the same individual of a psychoactive substance use disorder and another psychiatric disorder¼. It is considered to be a "border territory" since entails networking between different medical services. Materials and methods: A literature search was performed in PubMed, Web of Science, Scopus and Google Scholar. Search terms were: "guidelines", "treatment", "comorbidity", "substance abuse", "alcohol", "dual-diagnosis", "psychiatric illness", "outpatient", "inpatient", "health care service", "clinical practice". National and regional regulations about health and addiction were screened too. Out of 598 titles, 31 studies were included in this article for their relevance on treatments and networking between services for dual diagnosis cases. Results: There are not any guidelines for clinical practice in the literature, neither there are any shared treatment strategies on a national level. Considering the autonomy that every regional health service has, several different courses of action are possible. Here there are reported the ones available. Conclusions: After discussing the weak points of the treatment options, we suggest the "Multidisciplinary Healthcare" model to best address the difficulties represented by dual diagnosis cases.


Subject(s)
Alcoholism/therapy , Diagnosis, Dual (Psychiatry) , Mental Disorders/therapy , Alcoholism/rehabilitation , Community Mental Health Services/organization & administration , Community Networks/organization & administration , Deinstitutionalization/legislation & jurisprudence , Disease Management , Health Workforce/legislation & jurisprudence , Humans , Interdisciplinary Communication , Italy , Mental Disorders/rehabilitation , National Health Programs/organization & administration , Patient Care Team , Practice Guidelines as Topic , Rehabilitation Centers/organization & administration , Therapeutic Community
11.
Riv Psichiatr ; 53(3): 154-159, 2018.
Article in English | MEDLINE | ID: mdl-29912218

ABSTRACT

Background: The term "dual diagnosis" (DD) has been used in clinical practice for years. However, there is confusion about these medical cases, which consist in the presence of both a psychiatric disorder and a substance abuse disorder (in this case, alcohol). There are evidences that in the alcohol use disorder (AUD) population, 50.3% of patients had a psychiatric comorbidity during their lifetime. Nevertheless, to these days there are not any thorough guidelines for the management of these patients. A precise nosography would prevent delay in diagnosis and treatment and all the self-evident negative outcomes of those delays. Materials and methods: A literature search was performed in PubMed, Web of Science, and Scopus, including studies published between 1980 and 2015. Search terms were: "guidelines", "treatment", "comorbidity", "substance abuse", "alcohol", "dual-diagnosis", "etiopathogenesis", "outpatient", "inpatient", "unit", "diagnosis". Out of 1045 titles, 43 studies were included in this article for their relevance on definition and nosography of DD. Results: Taking into account the state of art available in the literature, we contributed to clarify the definition of DD in the alcohol addiction field. Clinical data confirm high prevalence of DD, and allow to better describe and understand the complex relationship between alcohol dependence and other psychiatric diseases. Conclusions: We believe that a clear nosographic framework and a precise diagnostic process are essential for a timely management of every case, using specific guidelines to standardize and improve clinical practice. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), which introduces dimensional approach, could be a useful tool to improve diagnostic accuracy.


Subject(s)
Alcoholism/diagnosis , Diagnosis, Dual (Psychiatry)/classification , Mental Disorders/diagnosis , Alcoholism/epidemiology , Alcoholism/therapy , Comorbidity , Diagnosis, Dual (Psychiatry)/statistics & numerical data , Diagnostic and Statistical Manual of Mental Disorders , Humans , International Classification of Diseases , Mental Disorders/epidemiology , Mental Disorders/therapy , Practice Guidelines as Topic
12.
Riv Psichiatr ; 53(3): 160-169, 2018.
Article in English | MEDLINE | ID: mdl-29912219

ABSTRACT

Background: It has long been appreciated that alcohol use disorder (AUD) is associated with increased risk of psychiatric disorder. As well, people with history of mental disorder are more likely to develop lifetime AUD. Nevertheless, the treatment of dual diagnosis (DD) in alcohol addiction still remains a challenge. The efficacy of pharmacological treatment for these patients has been widely investigated with controversial results. Patients with untreated psychiatric disorder are at higher risk to return to drinking and tend to do so more quickly. The aim of this review was to collect clinical data for developing guidelines for the pharmacological treatment of psychiatric diseases in a population with AUD. Materials and methods: A literature review was conducted using the following databases: PubMed-NCBI, Cochrane database, Embase Web of Science, and Scopus, including studies published between 1980 and 2015. Search terms were: "guideline", "treatment", "comorbidity", "substance abuse", "alcohol", "dual-diagnosis", "antidepressant", "antipsychotic", "mood-stabilizer". Out of 1521 titles, 84 studies were included for their relevance on pharmacological treatment of psychiatric disorders in people with AUD. Results: Different drugs were collected in major pharmacological classes (antidepressant, mood-stabilizer, antipsychotic), in order to identify their proved efficacy for treating specific psychiatric disorder in the AUD population. Data were selected and verified for publications from randomized clinical trials, open-label trials and case reports. Conclusions: DD in alcohol dependence is a complex clinical entity, and its high prevalence is supported by epidemiological data. Pharmacological management of psychiatric disorders in patients with AUD remains partially anecdotal. Based on reviewed articles, we propose a classification of psychiatric medications for treatment of mental disorders comorbid with AUD, listed with evidence-based recommendations. More research is needed to obtain and collect clinical data, in order to organize and share evidence-based guidelines.


Subject(s)
Alcohol Deterrents/therapeutic use , Alcoholism/drug therapy , Mental Disorders/drug therapy , Psychotropic Drugs/therapeutic use , Alcohol Deterrents/classification , Alcoholism/epidemiology , Anticonvulsants/therapeutic use , Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Clinical Trials as Topic , Comorbidity , Diagnosis, Dual (Psychiatry) , Evidence-Based Medicine , Humans , Mental Disorders/epidemiology , Practice Guidelines as Topic
13.
Can J Physiol Pharmacol ; 96(2): 128-136, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28763626

ABSTRACT

The present study was aimed at examining spatial learning and memory, in 33 men and 12 women with alcohol use disorder (AUD) undergoing ethanol detoxification, by using a virtual Morris task. As controls, we recruited 29 men and 10 women among episodic drinkers without a history of alcohol addiction or alcohol-related diseases. Elevated latency to the first movement in all trials was observed only in AUD persons; furthermore, control women had longer latencies compared with control men. Increased time spent to reach the hidden platform in the learning phase was found for women of both groups compared with men, in particular during trial 3. As predicted, AUD persons (more evident in men) spent less time in the target quadrant during the probe trial; however, AUD women had longer latencies to reach the platform in the visible condition during trials 6 and 7 that resulted in a greater distance moved. As for the probe trial, men of both groups showed increased virtual locomotion compared with the women of both groups. The present investigation confirms and extends previous studies showing (i) different gender responses in spatial learning tasks, (ii) some alterations due to alcohol addiction in virtual spatial learning, and (iii) differences between AUD men and AUD women in spatial-behaviour-related paradigms.


Subject(s)
Alcohol Abstinence , Task Performance and Analysis , User-Computer Interface , Adult , Alcoholism/physiopathology , Female , Humans , Male , Middle Aged , Reaction Time , Time Factors
14.
Psychol Psychother ; 89(3): 261-75, 2016 09.
Article in English | MEDLINE | ID: mdl-26454255

ABSTRACT

OBJECTIVES: We aimed to clarify the associations between negative emotionality, avoidant coping, and alexithymia. We hypothesized that negative emotionality and avoidance strategies would interact negatively in associating with alexithymia. DESIGN: We examined, in one study conducted in Italy and another in the US (total N = 415), the associations among avoidant coping, negative emotionality, and alexithymia, using cross-sectional designs. METHOD: Study 1: Participants completed paper-and-pencil measures of alexithymia, avoidant coping, and negative emotionality. Study 2: Participants completed the above-mentioned measures plus a measure of experiential avoidance (EA), by means of an online questionnaire. RESULTS: As expected, an antagonistic avoidant coping × negative emotionality interaction was found to relate to alexithymia in both studies. In Study 2, EA mediated the effects of such interaction on alexithymia (mediated moderation). The interaction found implied that alexithymia would be adopted as a defence against negative affect or as a consequence of avoidant strategies. CONCLUSIONS: The studies suggested that two different psychological pathways to alexithymia may be at work: Preference for avoidance and negative emotionality. This result appeared theoretically relevant and may stimulate further research. PRACTITIONER POINTS: Alexithymia may develop from habitual avoidance, regardless of negative emotionality. Practitioners could consider addressing negative emotional regulation or automatic and habitual avoidant responses in dealing with alexithymic patients.


Subject(s)
Affective Symptoms/diagnosis , Affective Symptoms/psychology , Avoidance Learning , Emotions , Pessimism/psychology , Adaptation, Psychological , Adult , Affective Symptoms/therapy , Cross-Sectional Studies , Female , Humans , Italy , Male , Middle Aged , Psychiatric Status Rating Scales , Surveys and Questionnaires , United States , Young Adult
15.
Riv Psichiatr ; 50(5): 216-27, 2015.
Article in Italian | MEDLINE | ID: mdl-26489071

ABSTRACT

Gambling disorder is a frequently underdiagnosed and disabling disorder with a prevalence greatly increased in recent decades. For various reasons, only a small part of pathological gamblers seek a support making difficult an early identification and delaying the administration of appropriate treatment. In DSM-5, the disorder has been reclassified from an "Impulse-Control Disorder not elsewhere classified" to one of the "Substance-Related and Addictive Disorders" with the intention of improve the diagnosis, to better targeting the treatment and to stimulating further research efforts directed to the disorder. This article reviews assessment techniques, psychosocial and neurobiological factors in the development of pathological gambling and treatment strategies.


Subject(s)
Behavior, Addictive/diagnosis , Behavior, Addictive/epidemiology , Gambling/diagnosis , Gambling/epidemiology , Behavior, Addictive/prevention & control , Comorbidity , Disruptive, Impulse Control, and Conduct Disorders/diagnosis , Disruptive, Impulse Control, and Conduct Disorders/epidemiology , Gambling/prevention & control , Humans , Incidence , Italy/epidemiology , Prevalence , Psychiatric Status Rating Scales , Psychotherapy/methods , Psychotropic Drugs/therapeutic use , Risk Assessment , Risk Factors
16.
Physiol Behav ; 149: 324-30, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-26143187

ABSTRACT

Alcohol dependence is a major public health problem worldwide. Brain and behavioral disruptions including changes in cognitive abilities are common features of alcohol addiction. Thus, the present study was aimed to investigate spatial learning and memory in 29 alcoholic men undergoing alcohol detoxification by using a virtual Morris maze task. As age-matched controls we recruited 29 men among occasional drinkers without history of alcohol dependence and/or alcohol related diseases and with a negative blood alcohol level at the time of testing. We found that the responses to the virtual Morris maze are impaired in men undergoing alcohol detoxification. Notably they showed increased latencies in the first movement during the trials, increased latencies in retrieving the hidden platform and increased latencies in reaching the visible platform. These findings were associated with reduced swimming time in the target quadrant of the pool where the platform had been during the 4 hidden platform trials of the learning phase compared to controls. Such increasing latency responses may suggest motor control, attentional and motivational deficits due to alcohol detoxification.


Subject(s)
Alcoholism/physiopathology , Alcoholism/therapy , Learning Disabilities/etiology , Spatial Learning/physiology , Adult , Analysis of Variance , Case-Control Studies , Humans , Male , Maze Learning/physiology , Middle Aged , Motor Activity/physiology , Reaction Time/physiology , Space Perception/physiology , User-Computer Interface
17.
Drug Alcohol Depend ; 145: 201-8, 2014 Dec 01.
Article in English | MEDLINE | ID: mdl-25456331

ABSTRACT

BACKGROUND: Maternal risk factors for fetal alcohol spectrum disorders (FASD) in Italy and Mediterranean cultures need clarification, as there are few studies and most are plagued by inaccurate reporting of antenatal alcohol use. METHODS: Maternal interviews (n = 905) were carried out in a population-based study of the prevalence and characteristics of FASD in the Lazio region of Italy which provided data for multivariate case control comparisons and multiple correlation models. RESULTS: Case control findings from interviews seven years post-partum indicate that mothers of children with FASD are significantly more likely than randomly-selected controls or community mothers to: be shorter; have higher body mass indexes (BMI); be married to a man with legal problems; report more drinking three months pre-pregnancy; engage in more current drinking and drinking alone; and have alcohol problems in her family. Logistic regression analysis of multiple candidate predictors of a FASD diagnosis indicates that alcohol problems in the child's family is the most significant risk factor, making a diagnosis within the continuum of FASD 9 times more likely (95%C.I. = 1.6 to 50.7). Sequential multiple regression analysis of the child's neuropsychological performance also identifies alcohol problems in the child's family as the only significant maternal risk variable (p < .001) when controlling for other potential risk factors. CONCLUSIONS: Underreporting of prenatal alcohol use has been demonstrated among Italian and other Mediterranean antenatal samples, and it was suspected in this sample. Nevertheless, several significant maternal risk factors for FASD have been identified.


Subject(s)
Alcohol Drinking/epidemiology , Alcohol Drinking/psychology , Body Mass Index , Fetal Alcohol Spectrum Disorders/epidemiology , Fetal Alcohol Spectrum Disorders/psychology , Maternal Behavior/psychology , Body Height/physiology , Case-Control Studies , Child , Cross-Sectional Studies , Female , Fetal Alcohol Spectrum Disorders/diagnosis , Humans , Italy/epidemiology , Male , Maternal Behavior/physiology , Pregnancy , Prenatal Exposure Delayed Effects/diagnosis , Prenatal Exposure Delayed Effects/epidemiology , Prenatal Exposure Delayed Effects/psychology , Risk Factors
18.
Riv Psichiatr ; 48(5): 359-69, 2013.
Article in English | MEDLINE | ID: mdl-24326748

ABSTRACT

It is now known that exposure to alcohol in utero produces a wide spectrum of morphological and behavioural outcomes in the offspring, commonly referred as fetal alcohol spectrum disorders (FASD). A large body of literature documents cognitive deficits and behavioural-emotional difficulties in children with FASD. Researchers have found that individuals with FASD often experience a range of adverse life outcomes, called secondary disabilities, which include disrupted school experience, troubles with the law, confinement, inappropriate sexual behaviours on repeated occasions, and alcohol/drug related problems. Additionally, despite considerable data published on cognitive and behavioural disabilities in children with FASD, relatively little information is available on behavioural or pharmacological interventions for alcohol affected children. This paper will provide a comprehensive review of the neuropsychological and behavioural effects of prenatal alcohol exposure, including a discussion of the emerging neurobehavioral profile. Finally, we will summarize published intervention studies of FASD focusing on their strengths and weaknesses.


Subject(s)
Fetal Alcohol Spectrum Disorders/diagnosis , Fetal Alcohol Spectrum Disorders/therapy , Child , Cognition Disorders/etiology , Humans , Mental Disorders/etiology , Neuropsychological Tests
19.
Addict Behav ; 37(11): 1224-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22727789

ABSTRACT

Alexithymia and avoidance coping strategies are both associated with alcohol abuse, but their effects have been seldom studied simultaneously. The present study investigated the interplay between alexithymia and avoidance coping strategies in predicting the severity of alcohol abuse in an alcohol-dependent sample. The TAS-20 and COPE-NVI questionnaires were administered to 110 alcoholic inpatients enrolled into a recovery program at the Center for Alcohol Abuse of the Department of Clinical Medicine, Sapienza University of Rome, Italy. The alcohol abuse index consisted of the mean alcohol units consumed by participants and days of abstinence before being enrolled into the recovery program. Results showed that alexithymic alcoholics consumed significantly more alcohol and were less abstinent than non-alexithymic alcoholics. Concerning the relationship among alexithymia, coping strategies and alcohol abuse, data showed that alexithymia completely mediated the effects of avoidance coping strategies on alcohol abuse, suggesting that avoidance strategies have therefore an indirect effect on alcohol abuse among alcoholics. Theoretical and clinical implications of the results are discussed.


Subject(s)
Adaptation, Psychological , Affective Symptoms/etiology , Alcoholism/psychology , Avoidance Learning , Adult , Alcoholism/rehabilitation , Analysis of Variance , Female , Humans , Male , Regression Analysis
20.
Int J Environ Res Public Health ; 8(6): 2331-51, 2011 06.
Article in English | MEDLINE | ID: mdl-21776233

ABSTRACT

OBJECTIVE: To determine the population-based epidemiology of fetal alcohol syndrome (FAS) and other fetal alcohol spectrum disorders (FASD) in towns representative of the general population of central Italy. METHODS: Slightly revised U.S. Institute of Medicine diagnostic methods were used among children in randomly-selected schools near Rome. Consented first grade children (n=976) were screened in Tier I for height, weight, or head circumference and all children≤10th centile on one of these measurements were included in the study. Also, teachers referred children for learning or behavioral problems. Children meeting either of these two criteria, along with randomly-selected controls, advanced to Tier II which began with a dysmorphology examination. Children with a possible FASD, and controls, advanced to Tier III for neurobehavioral testing, and their mothers were interviewed for maternal risks. Final diagnoses using indicators of dysmorphology, neurobehavior, and maternal risk were made in formally-structured, interdisciplinary case conferences. RESULTS: Case control comparisons of physical, neurobehavioral, and maternal risk variables are presented for 46 children with an FASD and 116 randomly-selected controls without a diagnosis on the FASD continuum. Rates of diagnoses within the FASD continuum are then estimated from these in-school data via three different methods. The range of rates of FAS produced by these methods is between 4.0 to 12.0 per 1,000; Partial FAS ranges from 18.1 to 46.3 per 1,000; and an FASD was found in 2.3% to 6.3% of the children. CONCLUSIONS: These rates are substantially higher than previous estimates of FAS and overall FASD for the general populations of Western Europe and the U. S., and raise questions as to the total impact of FASD on mental deficit in mainstream populations of Western Europe and the United States where the majority are middle class and are not believed to be characterized by heavy episodic drinking.


Subject(s)
Child Development Disorders, Pervasive/epidemiology , Fetal Alcohol Spectrum Disorders/epidemiology , Adult , Alcohol Drinking , Child , Child Development Disorders, Pervasive/chemically induced , Child Development Disorders, Pervasive/diagnosis , Female , Humans , Interviews as Topic , Italy/epidemiology , Male , Pregnancy , Pregnancy Complications , Severity of Illness Index , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...